The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1 dose escalation study of the IDH1m inhibitor, FT-2102, in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
 
Justin M. Watts
Consulting or Advisory Role - Jazz Pharmaceuticals
Speakers' Bureau - Jazz Pharmaceuticals
Research Funding - Takeda
 
Maria R. Baer
No Relationships to Disclose
 
Sangmin Lee
Consulting or Advisory Role - Alexion Pharmaceuticals; Amgen; AstraZeneca; Helsinn Healthcare
Research Funding - CTI; FORMA Therapeutics; Janssen; LAM Therapeutics; MedImmune; Stemline Therapeutics
Travel, Accommodations, Expenses - Arog
 
Jay Yang
No Relationships to Disclose
 
Shira Naomi Dinner
Consulting or Advisory Role - NS Pharma; Pfizer
Speakers' Bureau - Amgen
Research Funding - Astellas Oncology; FLX Bio; FORMA Therapeutics; Juno Therapeutics
 
Thomas Prebet
Honoraria - Boston Biomedical; Otsuka
Consulting or Advisory Role - Boston Biomedical; Otsuka
 
Gary J. Schiller
Research Funding - FORMA Therapeutics
 
Karen Seiter
Employment - Hudson Valley Cancer Center
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); incyte (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Agios; Celgene; Novartis
 
Paul Brent Ferrell
Research Funding - Incyte
 
Patrick Francis Kelly
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
 
Ping Li
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; FORMA Therapeutics; GlaxoSmithKline
 
Jennifer Sweeney
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics; Pfizer
 
Courtney Watson
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics; Synageva Biopharma
Consulting or Advisory Role - Rodin Therapeutics
 
Hesham Mohamed
Employment - FORMA Therapeutics
Stock and Other Ownership Interests - FORMA Therapeutics
Travel, Accommodations, Expenses - FORMA Therapeutics
 
Jorge E. Cortes
Consulting or Advisory Role - Amphivena Therapeutics; Astellas Pharma; Bio-Path Holdings, Inc; BiolineRx; Bristol-Myers Squibb; Daiichi Sankyo; Novartis; Pfizer; Takeda
Research Funding - Ambit BioSciences (Inst); Arog (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Celator (Inst); Celgene (Inst); Immunogen (Inst); Novartis (Inst); Pfizer (Inst); Sun Pharma (Inst); Takeda (Inst)